Idaho Business Times
SEE OTHER BRANDS

Fresh business and economy news from Idaho

Idaho Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Business Times.

Press releases published on September 18, 2025

ServiceTitan Introducing the Next Evolution of AI at Pantheon 2025 Keynote Sessions
SchooLinks Introduces the Agentic Layer: AI That Moves Beyond the Chatbot
AlixPartners appoints Hoyoung Pak to newly created role of Chief AI Officer
Defiance ETFs Unveils $ETHI: First-Ever Leveraged Ethereum ETF with Weekly Income*
Final 2025 Porsche Classic Restoration Challenge competitors announced
Defiance ETFs Launches QLDY, the First ETF to Pay Distributions Twice Weekly *
Join Global Leaders at the 17th Annual Capital Link New York Maritime Forum
N2OFF Announces Reverse Stock Split
Automated and Closed Cell Therapy Processing Systems Market Size to Grow at 19.84% CAGR
Fortune Media and Great Place To Work Name Basis Technologies to 2025 Best Workplaces in Advertising & Marketing List, Ranking No. 1
Study Shows 35% Cost Savings for Medicare Plans While Maintaining High-Quality Outcomes for Patients Living With Serious Illness
Bollinger Innovations, Inc. Announces Reverse Stock Split Effective Sept. 22, 2025
LPL Financial Welcomes Worley Monroe Advisors
Automatic Trap Company, the USA Distributor for Kiwi-Designed Goodnature Traps, Announces Its New Zealand-Based Supplier Wins a Global Innovation Honor for Its Rodent Control Products
Wine Growers Canada Brings Come Over October™ 2025 to Canada
Vestand Signs Agreement to Acquire Controlling Interest in AI Mindbot Equity
CHARTER COMMUNICATIONS INVESTORS: Charter has been Sued for Securities Fraud after Significant Customer Decline -- Contact BFA Law by October 14 Court Deadline
LINEAGE INVESTORS: Lineage, Inc. has been Sued for Securities Violations after Significant Downturn -- Contact BFA Law by September 30 Court Deadline
RXSIGHT INVESTORS: New RxSight, Inc. Securities Class Action Filed relating to LDD Sales -- Contact BFA Law by September 22 Court Deadline
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1–19) Cohort in VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions